NCT04089176

Carbetocin Versus Oxytocin for Prevention of Postcesarean Hemorrhage in Pregnancy With High Risk for PPH

Carbetocin Versus Oxytocin for Prevention of Postcesarean Hemorrhage in Pregnant Women With High Risk Postpartum Hemorrhage: a Randomized Controlled Trial

• Status: Completed
• Phase: EARLY_Phase 1
• Study type: Interventional
• Enrollment: 120 (actual)
• Sponsor: Department of Medical Services Ministry of Public Health of Thailand · Other Government
• Sex: Female
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

Objective: study efficacy of carbtocin versus oxytocin for prevention postpartum hemorrhage in high risk pregnancy who undergo cesarean section

Detailed description

Randomized controlled clinical trial. Defined patient in two group. Primary outcome is evaluate additional drug use Secondary outcome is evaluated estimated blood loss, hemoglobin level

Conditions

• Postpartum Hemorrhage
• Cesarean Section
• High Risk Pregnancy

Interventions

Type	Name	Description
DRUG	Carbetocin	carbetocin 100 mcg + RLS solution 10 ml injected directly into the vein over 2 min
DRUG	oxytocin	oxytocin 20 IU diluted in 1000 ml of RLS solution administered intravenously at rate 120 ml/hr x 8 hr

Timeline

• Start date: 2019-02-01
• Primary completion: 2019-04-30
• Completion: 2019-05-31
• First posted: 2019-09-13
• Last updated: 2019-09-13

Locations

1 site across 1 country: Thailand